Shares of hVIVO plc (LON:HVO – Get Free Report) traded down 6.8% on Thursday . The company traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares changed hands during trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.26).
hVIVO Trading Down 6.8 %
The stock has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61. The company has a 50-day simple moving average of GBX 23.58 and a 200-day simple moving average of GBX 26.77.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Bank Stocks – Best Bank Stocks to Invest In
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
